2-(3,4-dichlorophenyl)-2-methyl-N-(4-(N-(5-methylisoxazol-3-yl)sulfamoyl)phenyl)propanamide

ID: ALA3108855

PubChem CID: 53255423

Max Phase: Preclinical

Molecular Formula: C20H19Cl2N3O4S

Molecular Weight: 468.36

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(NS(=O)(=O)c2ccc(NC(=O)C(C)(C)c3ccc(Cl)c(Cl)c3)cc2)no1

Standard InChI:  InChI=1S/C20H19Cl2N3O4S/c1-12-10-18(24-29-12)25-30(27,28)15-7-5-14(6-8-15)23-19(26)20(2,3)13-4-9-16(21)17(22)11-13/h4-11H,1-3H3,(H,23,26)(H,24,25)

Standard InChI Key:  DBKRAZSTNZDPHZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 32  0  0  0  0  0  0  0  0999 V2000
    4.5826   -7.1129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1756   -7.8215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9928   -7.8197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8388   -5.4710    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.2494   -6.1776    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6560   -5.4688    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2928   -6.7008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0023   -7.1108    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7102   -6.7024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4128   -7.1128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1237   -6.7065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1237   -5.8856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4128   -5.4793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7102   -5.8856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8357   -4.6479    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.5190   -3.3530    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7025   -3.4387    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5377   -4.2362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2471   -4.6447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8514   -4.0980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6540   -4.2672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2920   -5.8836    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8740   -6.7059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8776   -5.8909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1698   -5.4839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4621   -5.8942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4665   -6.7156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1749   -7.1188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7623   -7.1277    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.7561   -5.4876    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  1  3  1  0
  5  4  2  0
  4  6  2  0
  7  1  1  0
  8  7  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  9 14  2  0
  4 15  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 16 20  1  0
 20 21  1  0
 15 18  1  0
 12  4  1  0
  7 22  2  0
  1 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 27 29  1  0
 26 30  1  0
M  END

Associated Targets(non-human)

pfk 6-phospho-1-fructokinase, putative (79 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
pfk 6-phospho-1-fructokinase (7870 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 468.36Molecular Weight (Monoisotopic): 467.0473AlogP: 5.01#Rotatable Bonds: 6
Polar Surface Area: 101.30Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 5.88CX Basic pKa: 0.38CX LogP: 5.00CX LogD: 4.14
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.53Np Likeness Score: -2.13

References

1. Brimacombe KR, Walsh MJ, Liu L, Vásquez-Valdivieso MG, Morgan HP, McNae I, Fothergill-Gilmore LA, Michels PA, Auld DS, Simeonov A, Walkinshaw MD, Shen M, Boxer MB..  (2014)  Identification of ML251, a Potent Inhibitor of T. brucei and T. cruzi Phosphofructokinase.,  (1): [PMID:24900769] [10.1021/ml400259d]
2. Miana GE, Ribone SR, Vera DMA, Sánchez-Moreno M, Mazzieri MR, Quevedo MA..  (2019)  Design, synthesis and molecular docking studies of novel N-arylsulfonyl-benzimidazoles with anti Trypanosoma cruzi activity.,  165  [PMID:30641409] [10.1016/j.ejmech.2019.01.013]

Source